Peter Krusche leads the AI & Data Engineering team in the Development > Advanced Quantitative Sciences > Technology & AI function at Novartis. This team focuses on using modern computational and engineering methods, as well as artificial intelligence, to accelerate research and automate the collection and aggregation of data from clinical trials — including clinical, imaging, omics, and other modalities. Peter's background is in computer science and he has 25 years of professional experience in a wide range of computational topics, ranging across artificial intelligence, bioinformatics, next-generation sequencing, systems biology, and software engineering.